Yes, cefuroxime is considered a broad-spectrum antibiotic.
Cefuroxime is classified as a broad-spectrum, second-generation cephalosporin with activity against both Gram-positive and Gram-negative bacteria 1. This designation is explicitly stated in FDA labeling and consistently referenced across multiple clinical guidelines.
Spectrum of Activity
Cefuroxime demonstrates clinically relevant activity against:
Gram-positive organisms:
- Staphylococcus aureus (methicillin-susceptible)
- Streptococcus pneumoniae
- Streptococcus pyogenes
- Staphylococcus epidermidis
Gram-negative organisms:
- Haemophilus influenzae
- Escherichia coli
- Klebsiella species
- Enterobacter species
- Neisseria species (including N. meningitidis and N. gonorrhoeae)
- Moraxella catarrhalis
- Proteus mirabilis
Clinical Context and Limitations
While cefuroxime is broad-spectrum, its activity is more limited compared to third-generation cephalosporins, particularly against Gram-negative organisms. The 2004 IDSA rhinosinusitis guidelines note that cefuroxime axetil has activity against S. pneumoniae similar to cefpodoxime and cefdinir, but is less active than cefpodoxime against H. influenzae 2.
Important resistance considerations:
- Cefuroxime is less active against S. pneumoniae than third-generation cephalosporins like cefotaxime or ceftriaxone 3
- Among penicillin-resistant pneumococci, cefuroxime covers only about 50% of isolates, compared to >90% coverage by cefotaxime 3
- It has no activity against MRSA, ESBL-producing organisms, or Pseudomonas aeruginosa
Guideline Recognition
Multiple international guidelines recognize cefuroxime as a broad-spectrum agent suitable for empiric therapy:
- WHO Essential Medicines List (2024): Recommends cefuroxime (with metronidazole) as a first-line option for mild-to-moderate intra-abdominal infections 4
- IDSA/WSES Guidelines: Include cefuroxime for surgical prophylaxis and treatment of skin/soft tissue infections 5, 6, 7
- Community-acquired pneumonia guidelines: Recognize cefuroxime as an acceptable second-generation cephalosporin option, though third-generation agents are often preferred 3
The term "broad-spectrum" is appropriate for cefuroxime because it covers the major respiratory, urinary, and skin pathogens encountered in community settings, though clinicians should recognize its relative limitations compared to newer cephalosporins when treating resistant organisms or severe infections 8.